Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 621

1.

The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention-A pilot study.

Lauridsen MM, Mikkelsen S, Svensson T, Holm J, Klüver C, Gram J, Vilstrup H, Schaffalitzky de Muckadell OB.

PLoS One. 2017 Oct 11;12(10):e0185412. doi: 10.1371/journal.pone.0185412. eCollection 2017.

2.

Lactulose enemas in the treatment of hepatic encephalopathy. Do we help or harm?

de Lorenzo-Pinto A, García-Sánchez R, Lorenzo-Salinas A.

Rev Esp Enferm Dig. 2017 Oct;109(10):736-737. doi: 10.17235/reed.2017.5106/2017.

3.

Assessment of the pharmacokinetics, removal rate of hemodialysis, and safety of lactulose in hemodialysis patients.

Lin CJ, Pan CF, Ju SY, Tzeng HK, Chen SW, Syu JT, Wu CJ.

J Food Drug Anal. 2016 Oct;24(4):876-880. doi: 10.1016/j.jfda.2016.05.007. Epub 2016 Aug 29.

4.

Lactulose decreases neuronal activation and attenuates motor behavioral deficits in hyperammonemic rats.

Mendes NF, Mariotti FFN, de Andrade JS, de Barros Viana M, Céspedes IC, Nagaoka MR, Le Sueur-Maluf L.

Metab Brain Dis. 2017 Sep 5. doi: 10.1007/s11011-017-0098-x. [Epub ahead of print]

PMID:
28875419
5.

Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy.

Kang SH, Lee YB, Lee JH, Nam JY, Chang Y, Cho H, Yoo JJ, Cho YY, Cho EJ, Yu SJ, Kim MY, Kim YJ, Baik SK, Yoon JH.

Aliment Pharmacol Ther. 2017 Nov;46(9):845-855. doi: 10.1111/apt.14275. Epub 2017 Aug 24.

PMID:
28836723
6.

Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.

Ahire K, Sonawale A.

J Assoc Physicians India. 2017 Aug;65(8):42-46.

PMID:
28799305
7.

L-ornithine L-aspartate in bouts of overt hepatic encephalopathy.

Sidhu SS, Sharma BC, Goyal O, Kishore H, Kaur N.

Hepatology. 2017 Jul 27. doi: 10.1002/hep.29410. [Epub ahead of print]

PMID:
28749571
8.

Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options.

Elwir S, Rahimi RS.

J Clin Transl Hepatol. 2017 Jun 28;5(2):142-151. doi: 10.14218/JCTH.2016.00069. Epub 2017 May 4. Review.

9.

Gastrointestinal Motility Disorders and Their Clinical Implications in Cirrhosis.

Theocharidou E, Dhar A, Patch D.

Gastroenterol Res Pract. 2017;2017:8270310. doi: 10.1155/2017/8270310. Epub 2017 May 11. Review.

10.

A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.

Pantham G, Post A, Venkat D, Einstadter D, Mullen KD.

Dig Dis Sci. 2017 Aug;62(8):2166-2173. doi: 10.1007/s10620-017-4630-y. Epub 2017 May 30.

PMID:
28560484
11.

'All that glitters is not gold': when hyperammonaemia is not from hepatic aetiology.

Hassan AAI, Ibrahim W, Subahi A, Mohamed A.

BMJ Case Rep. 2017 May 22;2017. pii: bcr-2017-219441. doi: 10.1136/bcr-2017-219441.

PMID:
28536219
12.

Hepatic encephalopathy.

Ferenci P.

Gastroenterol Rep (Oxf). 2017 May;5(2):138-147. doi: 10.1093/gastro/gox013. Epub 2017 Apr 18.

13.

Branched-chain amino acids for people with hepatic encephalopathy.

Gluud LL, Dam G, Les I, Marchesini G, Borre M, Aagaard NK, Vilstrup H.

Cochrane Database Syst Rev. 2017 May 18;5:CD001939. doi: 10.1002/14651858.CD001939.pub4. Review.

PMID:
28518283
14.
15.

[Correlation factor analysis on constipation in long-term ventilated patients in intensive care unit: a prospective observational cohort study].

Dai M, Wang H, Li K, Yu B, Pan X.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Jan;29(1):75-80. doi: 10.3760/cma.j.issn.2095-4352.2017.01.016. Chinese.

16.

Unexpected side effect in mCRC: A care-compliant case report of regorafenib-induced hyperammonemic encephalopathy.

Quirino M, Rossi S, Schinzari G, Basso M, Strippoli A, Cassano A, Barone C.

Medicine (Baltimore). 2017 Apr;96(16):e6522. doi: 10.1097/MD.0000000000006522.

17.

Hepatic encephalopathy: what the multidisciplinary team can do.

Liu A, Yoo ER, Siddique O, Perumpail RB, Cholankeril G, Ahmed A.

J Multidiscip Healthc. 2017 Mar 24;10:113-119. doi: 10.2147/JMDH.S118963. eCollection 2017. Review.

19.
20.

Probiotics for people with hepatic encephalopathy.

Dalal R, McGee RG, Riordan SM, Webster AC.

Cochrane Database Syst Rev. 2017 Feb 23;2:CD008716. doi: 10.1002/14651858.CD008716.pub3. Review.

PMID:
28230908

Supplemental Content

Loading ...
Support Center